Moderna stock tumbles after quarterly earnings show revenue declines

Moderna Chief Medical Officer Dr. Paul Burton acknowledges while governments are trying to protect health care systems, COVID restrictions over omicron are making people anxious.. fell after the company lowered its sales guidance for 2022 and missed revenue expectations for the third quarter.

Previously, the COVID-19 vaccine maker estimated end-of-year revenue would land at $21 billion. But, on Thursday, it changed those expectations to between $18 and $19 billion. Syringes sit in front of a Moderna logo in this illustration from Nov. 27, 2021. Overall third-quarter net income for Moderna stands at $1.043 billion, down from $3.333 billion, or $7.70 a share, from the prior year. Revenue also fell from $4.9 billion to $3.3 billion by the end of September. Moderna's shares declined in early morning trading Thursday after the company released poor third-quarter earnings.

"Today's earnings continue to show strong corporate momentum," Stéphane Bancel, Moderna's CEO, said in a statement to investors. "With $13.

poison

Couldn't happen to a better group of deceitful b*stards!

Delighted

Because it doesn’t prevent nor prevent the transmission of Covid.

España Últimas Noticias, España Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

From Apple to Disney, China's Covid curbs are again hurting business | CNN BusinessIt has been almost three years since Covid-19 first hit China, but the country's relentless adherence to lockdowns continues to hobble business and the economy. While killing fewer of its citizens, and giving fewer long covid. But keep on with that hyper capitalist propaganda y’all! CN FOX Yet the country continues to outsmart USA in all areas?
Fuente: cnni - 🏆 326. / 59 Leer más »